About Mona Ashiya
Mona Ashiya is a director at Yarrow Bioscience.
Form D filings name Mona Ashiya as a director at Vanqua Bio.
Mona Ashiya reports to the SEC as a director or major shareholder of 4 public companies, including Shattuck Labs (STTK), Disc Medicine (IRON) and Sierra Oncology (SRRA).
Mona Ashiya appears on fund filings for OrbiMed Partners.
Mona Ashiya first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Mona Ashiya in the role, so the role may have started earlier or lasted longer.
OP
YI
Yarrow Bioscience, Inc.
Director
2026 · Public company (YARW)
SI
Shattuck Labs, Inc.
Director
2025 – 2026 · Public company (STTK)
DI
Disc Medicine, Inc.
Director and 10% owner
2023 – 2025 · Public company (IRON)
SI
Sierra Oncology, Inc.
Director and 10% owner
2019 – 2022 · Public company (SRRA)
Key Colleagues at Startups
The people Mona Ashiya works with at each company, as listed on that company's latest Form D.
Vanqua Bio, Inc. · Form D, Jul 5, 2024
JS
Jonathan Silverstein
Director
RS
Rand Sutherland
Director
BD
Bernard Davitian
Director
UC
Uya Chuluunbaatar
Director
JS
James Sullivan
Chief Executive Officer and director